AdheRence to Inhaled Corticosteroids in Asthma (ARICA)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03769519|
Recruitment Status : Completed
First Posted : December 7, 2018
Last Update Posted : September 14, 2020
|Condition or disease||Intervention/treatment||Phase|
|Medication Adherence Asthma||Behavioral: ARICA||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||30 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Primary Purpose:||Health Services Research|
|Official Title:||AdheRence to Inhaled Corticosteroids in Asthma|
|Actual Study Start Date :||February 27, 2020|
|Actual Primary Completion Date :||August 19, 2020|
|Actual Study Completion Date :||August 19, 2020|
No Intervention: Control (Group 1)
This group is considered the control group. This group will have scheduled texts and emails for the monthly surveys after the participant completes the baseline questionnaires.
Experimental: ARICA Intervention (Group 2)
This group is considered the intervention group. Participants in this group will receive weekly texts and emails containing asthma facts and myths. They will also complete monthly surveys and participate in asthma education sessions.
Personalized ARICA (AdheRence to Inhaled Corticosteroids in Asthma) intervention package.
- Participant experiences with and perceptions of the ARICA program [ Time Frame: 3 months ]Assessment of participants experiences with and perceptions of the ARICA program, as assessed by in-depth semi-structured qualitative interview
- Change in patient reported medication adherence as measured by the Voils Adherence Questionnaire [ Time Frame: 3 months ]patients' medication adherence rates based on Voils adherence questionnaire adherence questionnaire
- Change in Asthma Control as measured by the Asthma Control Test [ Time Frame: 3 months ]patient reported
- Change in Asthma-Related Quality of Life as measured by the Marks Asthma-Related Quality of Life Questionnaire [ Time Frame: 3 months ]patient reported
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03769519
|United States, North Carolina|
|Durham, North Carolina, United States, 27701|
|Principal Investigator:||Isaretta L Riley, MD||Duke Un.|